<?xml version="1.0" encoding="UTF-8"?>
			<!DOCTYPE mcrj.edwiserinternational.com [
<!ELEMENT channel (title,link,description,language,managingEditor,webMaster,copyright,image,item)>
<!ELEMENT title (#PCDATA)>
<!ELEMENT link (#PCDATA)>
<!ELEMENT language (#PCDATA)>
<!ELEMENT managingEditor (#PCDATA)>
<!ELEMENT webMaster (#PCDATA)>
<!ELEMENT copyright (#PCDATA)>

<!ELEMENT image (title,link,url,width,height)>
<!ELEMENT url (#PCDATA)>
<!ELEMENT width (#PCDATA)>
<!ELEMENT height (#PCDATA)>

<!ELEMENT item (title,pubDate,link,author,comments,category,description)>
<!ELEMENT pubDate (#PCDATA)>
<!ELEMENT author (#PCDATA)>
<!ELEMENT comments (#PCDATA)>
<!ELEMENT category (#PCDATA)>
<!ELEMENT description (#PCDATA)>

]>
		<channel>
<title>Medical-Case-Reports-Journal-ISSUE VOLUME Volume 5 ISSUE Issue 2</title>
<link>http://mcrj.edwiserinternational.com/rss-feed.php</link>
<description>
Medical-Case-Reports-Journal: VOLUME Volume 5 ISSUE Issue 2, Jul-Dec 2022
</description>
<language>en-us</language>
<managingEditor>editor@edwiserinternational.com</managingEditor>
<webMaster>editor@edwiserinternational.com</webMaster>
<copyright>editor@edwiserinternational.com</copyright>
<image>
<title>Medical-Case-Reports-Journal-ISSUE VOLUME Volume 5 ISSUE Issue 2</title>
<link>http://mcrj.edwiserinternational.com/rss-feed.php</link>
<url>http://mcrj.edwiserinternational.com/img/logo1.png</url>
<width>360</width>
<height>109</height>
</image><item>
		<title>Treatment-of-Bowel-Syndrome-with-Constipation-An-Experience-with-the-Agonist-of-Guanylate-Cyclase-Receptor-in-Advanced-Age-Patients</title>
		<pubDate>17-Jan-2023</pubDate>
<link>http://mcrj.edwiserinternational.com/admin/uploads/G3gPb1.pdf</link>
		<author>Valerio-Massimo-Magro</author>
		<comments>{http://www.edwiserinternational.com/contact-us.php}</comments>
		<category>Pharmaceutical Science,Medical Science,Clinical Science</category>
		<description>{<![CDATA[The irritating bowel syndrome is a very common condition in the elderly, and it can also be extremely disabling being able to go to undermine the patient's independence. We wanted to conduct a study on the Territory, wanting to test a molecule recently approved for the treatment of variant with constipation-predominant irritable bowel syndrome, testing the treatment in a cohort of elderly subjects and comparing the results with those of other existing therapies. Here we expose the results of our experience.]]>}</description>
		</item></channel>